Skip to main content
Coreo AG logo

Coreo AG — Investor Relations & Filings

Ticker · CORE ISIN · DE000A40KYB8 LEI · 391200FQ2JQTU4IUY679 F Real estate activities
Open in API
Filings indexed 417 across all filing types
Latest filing 2008-08-22 Board/Management Inform…
Country DE Germany
Listing F CORE

About Coreo AG

https://coreo.de/en/

Coreo AG is a real estate investment company focused on the acquisition, development, and management of residential and commercial properties. The company's strategy centers on value-add opportunities, targeting properties with significant potential for appreciation. Coreo AG employs an active 'manage to core' approach to sustainably increase the value of its assets, with the goal of building and expanding an efficiently managed, high-yield real estate portfolio. Investment focus is primarily on residential properties, preferably in medium-sized centers, with individual investment volumes typically ranging from 5 to 20 million euros. The company's portfolio comprises a mix of residential, commercial, and combined-use properties.

Recent filings

Filing Released Lang Actions
Singapur: Nanostart berat Regierung
Board/Management Information Classification · 99% confidence The document is a short news release dated August 22, 2008, announcing that the CEO of Nanostart AG, Marco Beckmann, has been appointed to an expert committee (Final Evaluation Panel) for the Technology Enterprise Commercialisation Scheme (TECS) in Singapore, which deals with government subsidies for high-tech startups. This announcement concerns management involvement in external governmental/advisory roles, which relates to the company's governance and management structure, but it is primarily an announcement about a senior executive's activity. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a dividend notice (DIV). Given the content focuses on the appointment of a board member/executive to an external panel, it fits best under Board/Management Information (MANG), as it details management activity and recognition. It is too specific for the general Regulatory Filings (RNS) fallback.
2008-08-22 German
Investor Presentation 2008
Investor Presentation Classification · 98% confidence The document is a detailed research report titled "NANOTECHNOLOGY SMALL SCALE HIGH POTENTIAL INDUSTRIAL TOOL BOX" prepared by SILVIA QUANDT RESEARCH GMBH. It contains extensive analysis, market projections (e.g., US$2,600 BN for 2014), a table of contents, executive summary, detailed sections on the technology, case studies, and SWOT analysis. The length (287,357 characters) suggests it is a comprehensive document, not a brief announcement. This structure and depth are characteristic of an Investor Presentation (IP) or a detailed industry report, which aligns best with the 'Investor Presentation' definition, as it is clearly designed to inform and persuade investors about a specific technology sector's potential and investment opportunities.
2008-08-21 English
Singapores National Research Foundation invests 10 mn SGD in Nanostart Singapore Early Stage Venture Fund I
Regulatory Filings Classification · 99% confidence The document is a news release dated July 31, 2008, announcing that Nanostart Asia Pte Ltd. (a subsidiary of Nanostart AG) received a 10 million SGD investment from the Singapore government's National Research Foundation (NRF) for its Early Stage Venture Fund I. This announcement details a specific financing activity—receiving venture capital funding for a fund focused on nanotechnology startups. This clearly aligns with the definition of 'Capital/Financing Update' (CAP), which covers company fundraising and capital structure changes. It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it describes a specific corporate finance event.
2008-07-31 English
Nanostart-Holding ItN Nanovation receives large order from the Gulf region
Regulatory Filings Classification · 95% confidence The document is a short news release dated July 4, 2008, announcing a major contract win for Nanostart-Holding ItN Nanovation regarding the delivery of wastewater treatment plants. It is explicitly transmitted by DGAP, which often handles regulatory news. The content is a specific business update (a large order) rather than a comprehensive financial report (like 10-K or IR), a management change (MANG), or a dividend announcement (DIV). Since it is a specific, non-standard announcement that doesn't fit the primary financial reporting categories, and it is not a presentation (IP) or a transcript (CT), the most appropriate general category for miscellaneous regulatory news announcements that don't fit elsewhere is 'Regulatory Filings' (RNS). Given the short length and the nature of the announcement (a news detail), it is not an announcement *of* a report (RPA).
2008-07-04 English
Nanostart Holding ItN Nanovation AG signs cooperation agreement with SJE Rhombus
Regulatory Filings Classification · 100% confidence The document is a 'News Details' release from Nanostart AG, transmitted by DGAP, announcing a 'cooperation agreement' with SJE Rhombus regarding the exclusive marketing of CFM systems in North America. It details a business development, expected sales impact, and includes standard corporate boilerplate and media contacts. This type of announcement, which details a significant business event or partnership but is not a formal financial report (like 10-K, IR, or ER), fits best under the general category for regulatory announcements that don't fit elsewhere, which is Regulatory Filings (RNS). It is not a Director's Dealing (DIRS), a Capital/Financing Update (CAP), or a Merger/Acquisition (TAR). Given its nature as a general corporate news release distributed via a regulatory news service (DGAP), RNS is the most appropriate classification.
2008-06-24 English
Nanostart Holding Curiox Establishes Sales Partnership in Korea with BioBud
M&A Activity Classification · 99% confidence The document is a press release titled "Nanostart Holding Curiox Establishes Sales Partnership in Korea with BioBud." It details a commercial agreement (sales partnership) between two entities, Curiox and BioBud, concerning the distribution of a product. This type of announcement, which reports on business development, strategic alliances, or commercial milestones rather than mandatory financial results (10-K, ER, IR) or governance changes (MANG, DIRS), typically falls under general regulatory announcements or miscellaneous corporate news. Since there is no specific category for 'Business Development' or 'Partnership Announcement' among the provided codes, and it is not a formal financial filing, the most appropriate fallback category is 'Regulatory Filings' (RNS), which serves as a general category for miscellaneous corporate news releases transmitted via regulatory channels (indicated by 'Release of a Corporate News, transmitted by DGAP'). The document length is substantial enough (6675 chars) that it is not merely an announcement of an attachment (RPA).
2008-05-26 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.